A Massachusetts biotech that has been flying under the radar since its foundation in 2021, Treeline Biosciences, has emerged with $200 million in funding for a trio of cancer drugs. The ...
Copyright © 2025 Insider Inc and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback